Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration. 2012

Alexander Kapustin, and Victoria Stepanova, and Natalia Aniol, and Douglas B Cines, and Alexei Poliakov, and Serge Yarovoi, and Tatiana Lebedeva, and Robin Wait, and Grigory Ryzhakov, and Yelena Parfyonova, and Yaroslav Gursky, and Hiromi Yanagisawa, and Mikhail Minashkin, and Robert Beabealashvilli, and Alexander Vorotnikov, and Alex Bobik, and Vsevolod Tkachuk
Faculty of Fundamental Medicine, MV Lomonosov Moscow State University, Moscow, Russia. alexander.kapustin@kcl.ac.uk

uPA (urokinase-type plasminogen activator) stimulates cell migration through multiple pathways, including formation of plasmin and extracellular metalloproteinases, and binding to the uPAR (uPA receptor; also known as CD87), integrins and LRP1 (low-density lipoprotein receptor-related protein 1) which activate intracellular signalling pathways. In the present paper we report that uPA-mediated cell migration requires an interaction with fibulin-5. uPA stimulates migration of wild-type MEFs (mouse embryonic fibroblasts) (Fbln5+/+ MEFs), but has no effect on fibulin-5-deficient (Fbln5-/-) MEFs. Migration of MEFs in response to uPA requires an interaction of fibulin-5 with integrins, as MEFs expressing a mutant fibulin-5 incapable of binding integrins (Fbln(RGE/RGE) MEFs) do not migrate in response to uPA. Moreover, a blocking anti-(human β1-integrin) antibody inhibited the migration of PASMCs (pulmonary arterial smooth muscle cells) in response to uPA. Binding of uPA to fibulin-5 generates plasmin, which excises the integrin-binding N-terminal cbEGF (Ca2+-binding epidermal growth factor)-like domain, leading to loss of β1-integrin binding. We suggest that uPA promotes cell migration by binding to fibulin-5, initiating its cleavage by plasmin, which leads to its dissociation from β1-integrin and thereby unblocks the capacity of integrin to facilitate cell motility.

UI MeSH Term Description Entries
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014568 Urokinase-Type Plasminogen Activator A proteolytic enzyme that converts PLASMINOGEN to FIBRINOLYSIN where the preferential cleavage is between ARGININE and VALINE. It was isolated originally from human URINE, but is found in most tissues of most VERTEBRATES. Plasminogen Activator, Urokinase-Type,U-Plasminogen Activator,Urinary Plasminogen Activator,Urokinase,Abbokinase,Kidney Plasminogen Activator,Renokinase,Single-Chain Urokinase-Type Plasminogen Activator,U-PA,Single Chain Urokinase Type Plasminogen Activator,U Plasminogen Activator,Urokinase Type Plasminogen Activator
D016326 Extracellular Matrix Proteins Macromolecular organic compounds that contain carbon, hydrogen, oxygen, nitrogen, and usually, sulfur. These macromolecules (proteins) form an intricate meshwork in which cells are embedded to construct tissues. Variations in the relative types of macromolecules and their organization determine the type of extracellular matrix, each adapted to the functional requirements of the tissue. The two main classes of macromolecules that form the extracellular matrix are: glycosaminoglycans, usually linked to proteins (proteoglycans), and fibrous proteins (e.g., COLLAGEN; ELASTIN; FIBRONECTINS; and LAMININ). Extracellular Matrix Protein,Matrix Protein, Extracellular,Matrix Proteins, Extracellular,Protein, Extracellular Matrix,Proteins, Extracellular Matrix
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018345 Mice, Knockout Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes. Knockout Mice,Mice, Knock-out,Mouse, Knockout,Knock-out Mice,Knockout Mouse,Mice, Knock out

Related Publications

Alexander Kapustin, and Victoria Stepanova, and Natalia Aniol, and Douglas B Cines, and Alexei Poliakov, and Serge Yarovoi, and Tatiana Lebedeva, and Robin Wait, and Grigory Ryzhakov, and Yelena Parfyonova, and Yaroslav Gursky, and Hiromi Yanagisawa, and Mikhail Minashkin, and Robert Beabealashvilli, and Alexander Vorotnikov, and Alex Bobik, and Vsevolod Tkachuk
November 1996, The Journal of biological chemistry,
Alexander Kapustin, and Victoria Stepanova, and Natalia Aniol, and Douglas B Cines, and Alexei Poliakov, and Serge Yarovoi, and Tatiana Lebedeva, and Robin Wait, and Grigory Ryzhakov, and Yelena Parfyonova, and Yaroslav Gursky, and Hiromi Yanagisawa, and Mikhail Minashkin, and Robert Beabealashvilli, and Alexander Vorotnikov, and Alex Bobik, and Vsevolod Tkachuk
September 1995, The Journal of biological chemistry,
Alexander Kapustin, and Victoria Stepanova, and Natalia Aniol, and Douglas B Cines, and Alexei Poliakov, and Serge Yarovoi, and Tatiana Lebedeva, and Robin Wait, and Grigory Ryzhakov, and Yelena Parfyonova, and Yaroslav Gursky, and Hiromi Yanagisawa, and Mikhail Minashkin, and Robert Beabealashvilli, and Alexander Vorotnikov, and Alex Bobik, and Vsevolod Tkachuk
January 2017, Advanced biomedical research,
Alexander Kapustin, and Victoria Stepanova, and Natalia Aniol, and Douglas B Cines, and Alexei Poliakov, and Serge Yarovoi, and Tatiana Lebedeva, and Robin Wait, and Grigory Ryzhakov, and Yelena Parfyonova, and Yaroslav Gursky, and Hiromi Yanagisawa, and Mikhail Minashkin, and Robert Beabealashvilli, and Alexander Vorotnikov, and Alex Bobik, and Vsevolod Tkachuk
February 2015, Biochimica et biophysica acta,
Alexander Kapustin, and Victoria Stepanova, and Natalia Aniol, and Douglas B Cines, and Alexei Poliakov, and Serge Yarovoi, and Tatiana Lebedeva, and Robin Wait, and Grigory Ryzhakov, and Yelena Parfyonova, and Yaroslav Gursky, and Hiromi Yanagisawa, and Mikhail Minashkin, and Robert Beabealashvilli, and Alexander Vorotnikov, and Alex Bobik, and Vsevolod Tkachuk
June 2004, The American journal of pathology,
Alexander Kapustin, and Victoria Stepanova, and Natalia Aniol, and Douglas B Cines, and Alexei Poliakov, and Serge Yarovoi, and Tatiana Lebedeva, and Robin Wait, and Grigory Ryzhakov, and Yelena Parfyonova, and Yaroslav Gursky, and Hiromi Yanagisawa, and Mikhail Minashkin, and Robert Beabealashvilli, and Alexander Vorotnikov, and Alex Bobik, and Vsevolod Tkachuk
February 2002, Journal of cell science,
Alexander Kapustin, and Victoria Stepanova, and Natalia Aniol, and Douglas B Cines, and Alexei Poliakov, and Serge Yarovoi, and Tatiana Lebedeva, and Robin Wait, and Grigory Ryzhakov, and Yelena Parfyonova, and Yaroslav Gursky, and Hiromi Yanagisawa, and Mikhail Minashkin, and Robert Beabealashvilli, and Alexander Vorotnikov, and Alex Bobik, and Vsevolod Tkachuk
September 2015, Stem cell research & therapy,
Alexander Kapustin, and Victoria Stepanova, and Natalia Aniol, and Douglas B Cines, and Alexei Poliakov, and Serge Yarovoi, and Tatiana Lebedeva, and Robin Wait, and Grigory Ryzhakov, and Yelena Parfyonova, and Yaroslav Gursky, and Hiromi Yanagisawa, and Mikhail Minashkin, and Robert Beabealashvilli, and Alexander Vorotnikov, and Alex Bobik, and Vsevolod Tkachuk
April 2002, The Journal of biological chemistry,
Alexander Kapustin, and Victoria Stepanova, and Natalia Aniol, and Douglas B Cines, and Alexei Poliakov, and Serge Yarovoi, and Tatiana Lebedeva, and Robin Wait, and Grigory Ryzhakov, and Yelena Parfyonova, and Yaroslav Gursky, and Hiromi Yanagisawa, and Mikhail Minashkin, and Robert Beabealashvilli, and Alexander Vorotnikov, and Alex Bobik, and Vsevolod Tkachuk
January 2007, The international journal of biochemistry & cell biology,
Alexander Kapustin, and Victoria Stepanova, and Natalia Aniol, and Douglas B Cines, and Alexei Poliakov, and Serge Yarovoi, and Tatiana Lebedeva, and Robin Wait, and Grigory Ryzhakov, and Yelena Parfyonova, and Yaroslav Gursky, and Hiromi Yanagisawa, and Mikhail Minashkin, and Robert Beabealashvilli, and Alexander Vorotnikov, and Alex Bobik, and Vsevolod Tkachuk
July 1999, Experimental cell research,
Copied contents to your clipboard!